Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-06-23
2009-02-10
Hui, San-ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S457000, C514S336000, C514S171000
Reexamination Certificate
active
07488734
ABSTRACT:
The present invention provides methods of inducing contraception which includes delivering to a female a composition containing a compound of formula I, or tautomers thereof, in a regimen which involves delivering one or more of a selective estrogen receptor modulator, wherein formula I is:and wherein R1-R5and Q1are defined as described herein. Methods of providing hormone replacement therapy and for treating carcinomas, dysfunctional bleeding, uterine leiomyomata, endometriosis, and polycystic ovary syndrome is provided which includes delivering a compound of formula I and a selective estrogen receptor modulator are also described.
REFERENCES:
patent: 5719136 (1998-02-01), Chwalisz et al.
patent: 6331562 (2001-12-01), Bhagwat et al.
patent: 6355648 (2002-03-01), Fensome et al.
patent: 6407101 (2002-06-01), Collins et al.
patent: 6436929 (2002-08-01), Zhang et al.
patent: 6521657 (2003-02-01), Fensome et al.
patent: 6566372 (2003-05-01), Zhi et al.
patent: 6583145 (2003-06-01), Fensome et al.
patent: 6946454 (2005-09-01), Fensome et al.
patent: 2002/0061875 (2002-05-01), Gast et al.
patent: 2002/0169198 (2002-11-01), Fensome et al.
patent: 2003/0083322 (2003-05-01), Kraemer et al.
patent: 2003/0092711 (2003-05-01), Zhang et al.
patent: 2003/0130505 (2003-07-01), Zhi et al.
patent: WO-00/38519 (2000-07-01), None
patent: WO 00/66555 (2000-11-01), None
patent: WO-00/66556 (2000-11-01), None
patent: WO 00/66570 (2000-11-01), None
patent: WO 00/66581 (2000-11-01), None
patent: WO-01/15108 (2001-03-01), None
Fensome et al, “Novel 5-Aryl-1,3-dihydro-indole-2-thiones: Potent, Orally Active Progesterone Receptor Agonists”, Bioorg. & Med. Chem. Lett., 13:1317-1320 (Apr. 7, 2003).
Winneker et al., “Nonsteroidal progesterone receptor modulators: Structure activity relationships”, Seminars Reprod. Med., 23(1):46-57 (Feb. 2005).
Fensome Andrew
Grubb Gary S.
Harrison Diane Deborah
Winneker Richard Craig
Carango, Esq. Paul
Howson & Howson LLP
Hui San-ming
Wyeth
LandOfFree
Methods of treating hormone-related conditions using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating hormone-related conditions using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating hormone-related conditions using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107590